<p>Alphamab Oncology has filed a next day disclosure return with the Hong Kong Stock Exchange, reporting the repurchase of 500,000 shares at a total aggregate price of HKD 4,833,510. The repurchased shares are being held as treasury shares. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alphamab Oncology published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251231-11973032), on December 31, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)</p>

09966

<p>Alphamab Oncology has disclosed a share repurchase of 500,000 shares for a total of HKD 4,833,510, as reported to the Hong Kong Stock Exchange. The shares will be held as treasury shares.</p>

Alphamab Oncology Files HKEX Disclosure on 500,000 Share Repurchase at HKD 4.83 Million